Citation

Cameron K., Kung D., Kalgutkar A., Kurumbail R., Miller R., Salatto C., Ward J., Withka J., Bhattacharya S., Boehm M., Borzilleri K., Brown J., Calabrese M., Caspers N., Cokorinos E., Conn E., Dowling M., Edmonds D., Eng H., Fernando D., Frisbie R., Hepworth D., Landro J., Mao Y., Rajamohan F., Reyes A., Rose C., Ryder T., Shavnya A., Smith A., Tu M., Wolford A., Xiao J.: Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy. Journal of Medicinal Chemistry, Volume 59 (17), 2016

Authors

Kimberly O. Cameron, Daniel W. Kung, Amit S. Kalgutkar, Ravi G. Kurumbail, Russell Miller, Christopher T. Salatto, Jessica Ward, Jane M. Withka, Samit K. Bhattacharya, Markus Boehm, Kris A. Borzilleri, Janice A. Brown, Matthew Calabrese, Nicole L. Caspers, Emily Cokorinos, Edward L. Conn, Matthew S. Dowling, David J. Edmonds, Heather Eng, Dilinie P. Fernando, Richard Frisbie, David Hepworth, James Landro, Yuxia Mao, Francis Rajamohan, Allan R. Reyes, Colin R. Rose, Tim Ryder, Andre Shavnya, Aaron C. Smith, Meihua Tu, Angela C. Wolford, Jun Xiao

Journal

Journal of Medicinal Chemistry

Year

2016

DOI

10.1021/acs.jmedchem.6b00866

Machine-readable

REST APIRDF